Ryght
Founded Year
2023Stage
Seed VC - III | AliveTotal Raised
$8.83MLast Raised
$3M | 5 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+34 points in the past 30 days
About Ryght
Ryght focuses on the optimization of clinical trials through artificial intelligence within the healthcare sector. The company offers a generative artificial intelligence (AI) platform that assists in site selection and feasibility processes for clinical research, allowing sponsors and Contract Research Organizations (CROs) to identify and activate research sites. The company's solutions help to facilitate the trial process and address administrative tasks, impacting patient enrollment. Ryght was formerly known as Synthetica Bio. It was founded in 2023 and is based in Anaheim, California.
Loading...
Ryght's Product Videos
ESPs containing Ryght
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The drug development strategy & compliance platforms market combines AI with regulatory automation and strategic decision-making tools to optimize drug development. These platforms leverage AI for regulatory documentation (including investigational new drug applications), compliance management, and portfolio optimization. Solutions include document automation, data integrity validation, knowledge …
Ryght named as Challenger among 9 other companies, including Veeva Systems, IQVIA, and Certara.
Ryght's Products & Differentiators
Ryght
Ryght is a GenAI platform for Healthcare and Life Sciences. We offer a free version (Ryght Preview) which includes a few preloaded copilots and document collections and several key features to help accelerate tasks. We offer a paid subscription (Ryght Enterprise) that includes subscription Tiers 1-4. Enterprise plans include a) More users b) Unlimited enterprise connections c) Custom endpoints and/or d) White label options for embedding in your commercial software and/or data and custom built copilots. We’re more than a GenAI platform. We’re the experts who do the tooling in the background for companies who don’t have the resources, time, and budget to do it themselves.
Loading...
Research containing Ryght
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Ryght in 5 CB Insights research briefs, most recently on Sep 25, 2025.
Sep 25, 2025 report
Book of Scouting Reports: AI in Preclinical Development
Aug 22, 2025 report
Book of Scouting Reports: Generative AI in Healthcare & Life Sciences
May 23, 2025
The AI in drug R&D market map
Expert Collections containing Ryght
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Ryght is included in 2 Expert Collections, including Generative AI.
Generative AI
2,951 items
Companies working on generative AI applications and infrastructure.
Artificial Intelligence (AI)
37,222 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Latest Ryght News
Oct 23, 2025
Ryght AI Assembles Renowned Medical Leaders to Guide Next Phase of Clinical Trial AI Innovation / Ryght’s distinguished board of scientific experts will guide the company’s research initiatives and strategic direction as it transforms clinical trial site selection, qualification, and activation through dynamic digital replicas of research facilities globally. LAGUNA BEACH, Calif., Oct. 7, 2025 /PRNewswire/ — Ryght AI , the clinical trials technology company behind breakthrough AI Site Twin technology, today announced the formation of its inaugural Scientific Advisory Board (SAB). This distinguished board will guide the company’s research initiatives and strategic direction as it transforms clinical trial site selection, qualification, and activation through dynamic digital replicas of research facilities globally. The SAB comprises globally recognized experts in oncology, hematology, dermatology, artificial intelligence, healthcare technology, and digital transformation. These leaders will provide Ryght AI with deep scientific and clinical insights, foster collaborative research with sponsors, and ensure the company’s platform roadmap aligns with real-world challenges in study feasibility, patient recruitment, and operational performance.
Ryght Frequently Asked Questions (FAQ)
When was Ryght founded?
Ryght was founded in 2023.
Where is Ryght's headquarters?
Ryght's headquarters is located at 1950 Corporate Way, Anaheim.
What is Ryght's latest funding round?
Ryght's latest funding round is Seed VC - III.
How much did Ryght raise?
Ryght raised a total of $8.83M.
Who are the investors of Ryght?
Investors of Ryght include Foothill Ventures, LDV Partners, Tarek Sherif, BioTools Innovator, NVIDIA Inception Program and 7 more.
Who are Ryght's competitors?
Competitors of Ryght include Layer Health and 2 more.
What products does Ryght offer?
Ryght's products include Ryght .
Who are Ryght's customers?
Customers of Ryght include BEK Health and Avance Clinical.
Loading...
Compare Ryght to Competitors
Autonomize is a company that provides healthcare AI solutions within the healthcare and life sciences sectors. Its offerings include tools that organize, contextualize, and summarize unstructured data to support decision-making and enhance patient outcomes. The company's technologies aim to improve clinical workflows and reduce the burden on healthcare professionals. It was founded in 2022 and is based in Austin, Texas.
Arctoris operates as a drug discovery services company that provides services including target validation, hit finding, hit-to-lead development, lead optimization, and preclinical studies, supported by an automated laboratory and data science platform. Arctoris serves various sectors, focusing on partners in the biotech and pharmaceutical industries. It was founded in 2016 and is based in Oxfordshire, United Kingdom.
Cytel is a clinical research organization that provides data science and analytics services for drug development. The company offers software solutions and consulting services for clinical trial design, implementation, and analysis, serving sectors within the life sciences industry, including pharmaceutical and biotechnology companies. Cytel provides expertise in adaptive trial designs, real-world evidence generation, and regulatory strategy. It was founded in 1987 and is based in Cambridge, Massachusetts.
Optibrium operates as a company focused on drug discovery software and artificial intelligence (AI) solutions within the pharmaceutical and biotech industries. It offers integrated software tools for small molecule design, optimisation, and data analysis, aimed at supporting the drug discovery process. The company's products include compound generation, optimisation, three-dimensional (3D) molecular design and visualisation, and AI data analysis to assist in drug development. It was founded in 2009 and is based in Cambridge, United Kingdom.
Envisagenics develops an AI-driven biotechnology company. Its product, SpliceCore, offers a platform for discovering novel targets to develop successful therapies. The company provides a cloud-based discovery platform that uses machine learning (ML) to prioritize new drug target candidates from patients' ribonucleic acid (RNA). It was founded in 2014 and is based in New York, New York.
Biovista provides augmented and artificial intelligence services within the healthcare sector, focusing on drug repositioning and personalized medicine. The company offers solutions for drug de-risking and analyzing clinical trial data, using AI in biopharma pipeline management. Biovista serves the biopharma industry, offering services to biotech and generics companies, as well as patient advocacy groups. It was founded in 2005 and is based in Charlottesville, Virginia.
Loading...